http://www.unboundmedicine.com/medline/ebm/research/cetuximabUnbound MEDLINE is a service provided by Unbound Medicine, Inc. that includes data and services from the U.S. National Library of Medicine's MEDLINE® and PubMed® databases.en-usUnbound Medicine, Inc.http://www.unboundmedicine.com/medline/ebm/record/19925598/full_citation/Cetuximab_induced_cutaneous_toxicity_Tomková H, Kohoutek M, Zábojníková M, et al. 
Cetuximab-induced cutaneous toxicity. [JOURNAL ARTICLE]
J Eur Acad Dermatol Venereol 2009 Nov 18.
Abstract | Full Citation | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/19923868/full_citation/Cetuximab_Based_Treatment_of_Metastatic_Anal_Cancer:_Correlation_of_Response_with_KRAS_Mutational_Status_Lukan N, Ströbel P, Willer A, et al. 
Cetuximab-Based Treatment of Metastatic Anal Cancer: Correlation of Response with KRAS Mutational Status. [JOURNAL ARTICLE]
Oncology 2009 Nov 17; 77(5):293-299.
Abstract | Full Citationhttp://www.unboundmedicine.com/medline/ebm/record/19923311/full_citation/Clinical_and_economic_value_of_screening_for_Kras_mutations_as_predictors_of_response_to_epidermal_growth_factor_receptor_inhibitors_Mancl EE, Kolesar JM, Vermeulen LC 
Clinical and economic value of screening for Kras mutations as predictors of response to epidermal growth factor receptor inhibitors. [JOURNAL ARTICLE]
Am J Health Syst Pharm 2009 Dec 1; 66(23):2105-2112.
Abstract | Full Citation | Publisher Full Text | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/19922468/full_citation/Epidermal_growth_factor_receptor_in_relation_to_tumor_development:_EGFR_targeted_anticancer_therapy_Okamoto I 
Epidermal growth factor receptor in relation to tumor development: EGFR-targeted anticancer therapy. [JOURNAL ARTICLE]
FEBS J 2009 Nov 18.
Abstract | Full Citation | Publisher Full Text | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/19921572/full_citation/[Effect_of_KRAS_mutation_on_efficacy_of_Cetuximab_combined_with_chemotherapy_in_advanced_colorectal_cancer_patients_]Pu XX, Deng YH, Xu F, et al. 
[Effect of KRAS mutation on efficacy of Cetuximab combined with chemotherapy in advanced colorectal cancer patients.] [JOURNAL ARTICLE]
Zhonghua Wei Chang Wai Ke Za Zhi 2009 Nov; 12(6):594-597.
Abstract | Full Citationhttp://www.unboundmedicine.com/medline/ebm/record/19917871/full_citation/American_Society_of_Clinical_Oncology_Clinical_Practice_Guideline_Update_on_Chemotherapy_for_Stage_IV_Non_Small_Cell_Lung_Cancer_Azzoli CG, Baker S, Temin S, et al. 
American Society of Clinical Oncology Clinical Practice Guideline Update on Chemotherapy for Stage IV Non-Small-Cell Lung Cancer. [JOURNAL ARTICLE]
J Clin Oncol 2009 Nov 16.
Abstract | Full Citation | Publisher Full Text | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/19917840/full_citation/Induction_Chemotherapy_and_Cetuximab_for_Locally_Advanced_Squamous_Cell_Carcinoma_of_the_Head_and_Neck:_Results_From_a_Phase_II_Prospective_Trial_Kies MS, Holsinger FC, Lee JJ, et al. 
Induction Chemotherapy and Cetuximab for Locally Advanced Squamous Cell Carcinoma of the Head and Neck: Results From a Phase II Prospective Trial. [JOURNAL ARTICLE]
J Clin Oncol 2009 Nov 16.
Abstract | Full Citation | Publisher Full Text | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/19917537/full_citation/Biomarkers_and_anti_EGFR_therapies_for_KRAS_wild_type_metastatic_colorectal_cancer_García-Sáenz JA, Sastre J, Díaz-Rubio García E 
Biomarkers and anti-EGFR therapies for KRAS wild-type metastatic colorectal cancer. [Journal Article]
Clin Transl Oncol 2009 Nov; 11(11):737-47.
Abstract | Full Citationhttp://www.unboundmedicine.com/medline/ebm/record/19916742/full_citation/A_Multicenter_Phase_II_Trial_of_Carboplatin_and_Cetuximab_for_Treatment_of_Advanced_Nonsmall_Cell_Lung_Cancer_Stinchcombe TE, Bradford DS, Hensing TA, et al. 
A Multicenter Phase II Trial of Carboplatin and Cetuximab for Treatment of Advanced Nonsmall Cell Lung Cancer. [JOURNAL ARTICLE]
Cancer Invest 2009 Nov 16.
Abstract | Full Citation | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/19915942/full_citation/Implications_of_KRAS_mutation_status_for_the_treatment_of_metastatic_colorectal_cancer_Ciardiello F, Tejpar S, Papamichael D 
Implications of KRAS mutation status for the treatment of metastatic colorectal cancer. [JOURNAL ARTICLE]
Target Oncol 2009 Nov 14.
Abstract | Full Citation